Serum lactate dehydrogenase (LDH) level as a prognostic factor for the patients with advanced gastric cancer

被引：0
|
作者：
Lee, H. [1 ]
Yuh, Y. [1 ]
Kim, S. [1 ]
机构：
[1] Sanggyepaik Hosp, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15621
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic Value of Baseline Serum Lactate Dehydrogenase Level in Patients With Hairy Cell Leukemia
    Maral, Senem
    Albayrak, Murat
    Dagdas, Simten
    Yildiz, Abdulkerim
    Yildirim, Rahsan
    Oz, Merih
    Pala, Cigdem
    Ozturk, Hacer Berna Afacan
    Bay, Ilker
    Ozet, Gulsum
    Dilek, Imdat
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (09): : E616 - E621
  • [32] Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma
    Blank, Christian U.
    Kelderman, Sander
    van Tinteren, Harm
    Heemskerk, Bianca
    van den Brom, Rob
    Hospers, Geke A.
    van den Eertwegh, Alfons J. M.
    Kapiteijn, Ellen
    De Groot, Jan Willem
    Jansen, Rob L.
    Fiets, W. Edward
    Krzystanek, Marcin
    Szallasi, Zoltan
    Furness, Andrew James Scott
    Renn, Alex
    Gore, Martin Eric
    Lorigan, Paul
    Schumacher, Ton
    Haanen, John B. A. G.
    Larkin, James M. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Marked Elevation of Serum Lactate Dehydrogenase (LDH) in Primary Myelofibrosis: Clinical and Prognostic Correlates
    Shah, Sahrish
    Mudireddy, Mythri
    Barraco, Daniela
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Gangat, Naseema
    Pardanani, Animesh
    Tefferi, Ayalew
    BLOOD, 2016, 128 (22)
  • [34] SERUM LACTATE-DEHYDROGENASE (LDH) AS A PROGNOSTIC INDEX FOR NON-HODGKINS LYMPHOMA
    ENDRIZZI, L
    FIORENTINO, MV
    SALVAGNO, L
    SEGATI, R
    PAPPAGALLO, GL
    FOSSER, V
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (10): : 945 - 949
  • [35] Serum lactate dehydrogenase as a novel prognostic factor for patients with primary undifferentiated pleomorphic sarcomas
    Lin, Qiaowei
    Sun, Zhengwang
    Yu, Lin
    Wang, Qifeng
    Zhu, Ping
    Jiang, Yihan
    Sun, Yangbai
    Yan, Wangjun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (04) : 1453 - 1463
  • [36] Serum lactate dehydrogenase as a novel prognostic factor for patients with primary undifferentiated pleomorphic sarcomas
    Qiaowei Lin
    Zhengwang Sun
    Lin Yu
    Qifeng Wang
    Ping Zhu
    Yihan Jiang
    Yangbai Sun
    Wangjun Yan
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1453 - 1463
  • [37] Prognostic value of serum lactate dehydrogenase (LDH) in patients with primary, systemic amyloidosis undergoing stem cell transplantation
    Kumar, Shaji
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne
    Buadi, Francis K.
    Dingli, David
    Litzow, Mark R.
    Gertz, Morie A.
    BLOOD, 2007, 110 (11) : 844A - 845A
  • [38] An Elevated Serum Lactate Dehydrogenase-to-albumin Ratio Is a Useful Poor Prognostic Predictor of Nivolumab in Patients With Gastric Cancer
    Nakazawa, Nobuhiro
    Sohda, Makoto
    Yamaguchi, Arisa
    Watanabe, Takayoshi
    Saito, Hideyuki
    Ubukata, Yasunari
    Kuriyama, Kengo
    Sano, Akihiko
    Sakai, Makoto
    Yokobori, Takehiko
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    ANTICANCER RESEARCH, 2021, 41 (08) : 3925 - 3931
  • [39] Serum lactate dehydrogenase level in patients with nasopharyngeal carcinoma
    Liaw, CC
    Wang, CH
    Huang, JS
    Kiu, MC
    Chen, JS
    Chang, HK
    ACTA ONCOLOGICA, 1997, 36 (02) : 159 - 164
  • [40] Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer
    Saito, H
    Tsujitani, S
    Ikeguchi, M
    Maeta, M
    Kaibara, N
    ONCOLOGY, 1999, 56 (03) : 253 - 258
12345